Viewing Study NCT05495035


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2026-01-03 @ 6:02 AM
Study NCT ID: NCT05495035
Status: UNKNOWN
Last Update Posted: 2023-03-02
First Post: 2022-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoblastic Leukemia, Acute, Childhood View
None Leukemia, Lymphoblastic, Acute, Philadelphia-Positive View
None Relapsed Leukemia View
None Refractory Leukemia View
Keywords: